Treatment of Glycogen Storage Disease Type IV in Neurogenic Bladder with Urinary Urgency, Frequency, and Incontinence

Patients with Glycogen storage disease type IV (GSD IV) who develop neurogenic bladder may experience a cluster of lower urinary tract symptoms — urinary urgency, increased urinary frequency, nocturia, and urinary incontinence — that require structured, evidence-informed management alongside the underlying metabolic condition.

Clinical scenario: GSD IV with co-existing neurogenic bladder, presenting with urinary urgency, urinary frequency, nocturia, and urinary incontinence.

First-line approach

Initial management centres on behavioral modifications — including adjustments to fluid intake patterns, avoidance of specific bladder irritants, and structured voiding strategies. Pelvic floor muscle training is also part of the first-line framework.

The complete structured regimen — full intervention details, sequencing, and individualised guidance — is in the protocol.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1016/j.ymgme.2023.107525

For patients with urgency, frequency, nocturia, and incontinence first-line treatment includes behavioral modifications such as fluid modulation (or restriction prior to going to bed), elimination of bladder irritants (e.g., caffeine, alcohol), timed voiding (i.e., voiding before urgency or incontinence typically occurs) and optimizing bowel function as well as pelvic floor muscle exercises.

View source ↗